Skip to Main Content
Legislation Search

S. 1104: Worldwide Animal Testing Compliance and Harmonization Act of 2025

This bill, known as the Worldwide Animal Testing Compliance and Harmonization Act of 2025 (also referred to as the WATCH Act), seeks to amend existing regulations regarding animal research conducted in foreign laboratories that receive federal funding. Here is a summary of the key components of the bill:

Inspection Requirements

The bill mandates that all foreign laboratories receiving federal funds for research involving animals must undergo quarterly inspections. The primary aim of these inspections is to ensure compliance with applicable animal welfare standards.

Inspection Process

  • The Secretary of Health, in consultation with relevant foreign regulatory authorities and international organizations, will be responsible for establishing a process to conduct these inspections.
  • The inspections will assess whether these laboratories:
    • Have appropriate animal care committees.
    • Conduct reviews and evaluations of animal care and treatment.
    • Maintain proper record-keeping and reporting procedures.

Certification of Compliance

After each inspection, if a laboratory meets the required standards, the inspecting authority will issue a certificate of compliance. This information will be made publicly accessible through the Office of Laboratory Animal Welfare, which will also provide other details concerning animal welfare assurances.

Addressing Non-compliance

  • Laboratories that are found to be non-compliant will be given a reasonable opportunity to correct any issues.
  • If a laboratory fails to comply after being given a chance to rectify the situation, the Secretary may suspend or revoke the relevant grants or contracts for research involving animals.

Coordination with Foreign Authorities

The Secretary and the Director of the National Institutes of Health (NIH) are required to work with foreign regulatory bodies and form agreements where necessary to ensure the enforcement of these inspections, while respecting the laws and sovereignty of each foreign nation.

Effective Date

The new regulations outlined in this bill will take effect 180 days after the bill is enacted.

Relevant Companies

  • PFE (Pfizer Inc.) - Could be impacted due to their involvement in animal research for drug development and testing.
  • NVS (Novartis AG) - As a pharmaceutical company involved in biomedical research, they may be affected by increased compliance regulations in foreign laboratories they work with.
  • BMY (Bristol-Myers Squibb Company) - Their operations in animal testing for research purposes may be influenced by new inspection and compliance requirements.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

7 bill sponsors

Actions

2 actions

Date Action
Mar. 25, 2025 Introduced in Senate
Mar. 25, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $15,001 - $50,000
Apr 07, 2025 Mar 31, 2025 -7.50%
Congress pfp
Greg Landsman D / House
BMY logo
BMY BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK
Sale $1,001 - $15,000
Apr 08, 2025 Mar 27, 2025 -16.08%
Congress pfp
George Whitesides D / House
NVS logo
NVS STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. NOVARTIS AG COMMON STOCK
Sale $100,001 - $250,000
Apr 23, 2025 Mar 24, 2025 +5.45%
Congress pfp
Carol D. Miller R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Apr 11, 2025 Mar 10, 2025 -11.60%
Congress pfp
Bruce Westerman R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Apr 16, 2025 Mar 03, 2025 -6.44%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Mar 06, 2025 Feb 26, 2025 -5.32%
Congress pfp
Robert Bresnahan R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $15,001 - $50,000
Mar 27, 2025 Feb 25, 2025 -6.42%
Congress pfp
Jefferson Shreve R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $15,001 - $50,000
Mar 09, 2025 Feb 24, 2025 -5.67%
Congress pfp
John Boozman R / Senate
PFE logo
PFE Pfizer Inc
Sale (Full) $1,001 - $15,000
Mar 06, 2025 Feb 13, 2025 -0.41%
Congress pfp
Julie Johnson D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Mar 12, 2025 Feb 12, 2025 -0.76%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 24, 2025 -2.21%
Congress pfp
Julie Johnson D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Feb 12, 2025 Jan 15, 2025 -4.95%
Congress pfp
Julie Johnson D / House
BMY logo
BMY BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK
Purchase $1,001 - $15,000
Feb 12, 2025 Jan 15, 2025 -7.57%
Congress pfp
Virginia Foxx R / House
BMY logo
BMY BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK
Purchase $1,001 - $15,000
Jan 06, 2025 Dec 06, 2024 -10.24%
Congress pfp
Laurel M. Lee R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $15,001 - $50,000
Nov 21, 2024 Oct 21, 2024 -14.58%
Congress pfp
Greg Landsman D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Nov 14, 2024 Oct 15, 2024 -16.57%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Sep 04, 2024 Aug 09, 2024 -22.46%
Congress pfp
Scott Franklin R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $15,001 - $50,000
Aug 20, 2024 Aug 06, 2024 -26.67%
Congress pfp
Scott Franklin R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Aug 20, 2024 Aug 01, 2024 -26.05%
Congress pfp
Tommy Tuberville R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Sale (Full) $15,001 - $50,000
Jun 14, 2024 May 03, 2024 -24.65%
Congress pfp
Sheldon Whitehouse D / Senate
NVS logo
NVS Novartis Ag ADR
Sale (Partial) $1,001 - $15,000
May 20, 2024 Apr 09, 2024 +11.09%
Congress pfp
Tommy Tuberville R / Senate
BMY logo
BMY Bristol-Myers Squibb Company Common Stock
Sale (Full) $1,001 - $15,000
May 15, 2024 Apr 03, 2024 -14.59%
Congress pfp
Tommy Tuberville R / Senate
BMY logo
BMY Bristol-Myers Squibb Company Common Stock
Purchase $1,001 - $15,000
May 15, 2024 Apr 03, 2024 -14.59%
Congress pfp
Roger Williams R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Jun 12, 2024 Mar 04, 2024 -18.35%
Congress pfp
Roger Williams R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Jun 12, 2024 Mar 01, 2024 -20.55%
Congress pfp
Roger Williams R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Jun 12, 2024 Mar 01, 2024 -20.55%
Congress pfp
Tommy Tuberville R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Purchase $1,001 - $15,000
Mar 15, 2024 Feb 27, 2024 -22.77%
Congress pfp
Earl Blumenauer D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Mar 02, 2024 Feb 12, 2024 -26.42%
Congress pfp
John James R / House
BMY logo
BMY BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK
Sale $1,001 - $15,000
Sep 02, 2024 Jan 18, 2024 -20.28%
Congress pfp
Rick Larsen D / House
BMY logo
BMY BRISTOL-MYERS SQUIBB COMPANY
Sale $1,001 - $15,000
Jan 19, 2024 Jan 09, 2024 -23.23%
Congress pfp
Tommy Tuberville R / Senate
BMY logo
BMY Bristol-Myers Squibb Company Common Stock
Sale (Partial) $1,001 - $15,000
Feb 14, 2024 Jan 03, 2024 -26.17%
Congress pfp
Jared Moskowitz D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jan 22, 2024 Dec 28, 2023 -35.26%
Congress pfp
Jared Moskowitz D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jan 22, 2024 Dec 28, 2023 -35.26%
Congress pfp
John Boozman R / Senate
PFE logo
PFE Pfizer Inc
Purchase $1,001 - $15,000
Jan 08, 2024 Dec 20, 2023 -34.03%
Congress pfp
Shelley Moore Capito R / Senate
PFE logo
PFE Pfizer Inc
Sale (Partial) $1,001 - $15,000
Jan 12, 2024 Dec 18, 2023 -30.83%
Congress pfp
Jerry Moran R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Sale (Full) $1,001 - $15,000
Jan 17, 2024 Dec 14, 2023 -28.29%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jan 12, 2024 Dec 12, 2023 -37.72%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC.
Sale $15,001 - $50,000
Jan 12, 2024 Dec 12, 2023 -37.72%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jan 12, 2024 Dec 12, 2023 -37.72%
Congress pfp
Sheldon Whitehouse D / Senate
PFE logo
PFE Pfizer Inc
Sale (Full) $1,001 - $15,000
Jan 18, 2024 Dec 11, 2023 -38.47%
Congress pfp
Tommy Tuberville R / Senate
BMY logo
BMY Bristol-Myers Squibb Company
Sale (Full) $1,001 - $15,000
Dec 15, 2023 Nov 16, 2023 -28.39%
Congress pfp
John James R / House
BMY logo
BMY BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK
Purchase $1,001 - $15,000
Sep 02, 2024 Nov 10, 2023 -30.62%
Congress pfp
Greg Stanton D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -53.91%
Congress pfp
Greg Stanton D / House
BMY logo
BMY BRISTOL-MYERS SQUIBB COMPANY
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -44.79%
Congress pfp
Tommy Tuberville R / Senate
BMY logo
BMY Bristol-Myers Squibb Company Common Stock
Purchase $1,001 - $15,000
Nov 16, 2023 Oct 17, 2023 -42.96%
Congress pfp
Greg Stanton D / House
BMY logo
BMY BRISTOL-MYERS SQUIBB COMPANY
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -47.10%
Congress pfp
Greg Stanton D / House
PFE logo
PFE PFIZER, INC.
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -57.31%
Congress pfp
Sheldon Whitehouse D / Senate
NVS logo
NVS Novartis Ag ADR
Purchase $15,001 - $50,000
Oct 17, 2023 Sep 20, 2023 -16.55%
Congress pfp
Scott Franklin R / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Oct 12, 2023 Sep 11, 2023 -54.52%
Congress pfp
Lois Frankel D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Oct 10, 2023 Sep 08, 2023 -55.93%
Congress pfp
Jared Moskowitz D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Aug 21, 2024 Sep 01, 2023 -57.21%
Congress pfp
Dan Sullivan R / Senate
BMY logo
BMY Bristol-Myers Squibb Company
Sale (Full) $1,001 - $15,000
Sep 18, 2023 Aug 22, 2023 -48.31%
Congress pfp
Tommy Tuberville R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Purchase $1,001 - $15,000
Aug 14, 2023 Jul 25, 2023 -58.30%
Congress pfp
Daniel S. Goldman D / House
BMY logo
BMY BRISTOL-MYERS SQUIBB COMPANY
Sale $15,001 - $50,000
Aug 13, 2023 Jul 12, 2023 -46.65%
Congress pfp
Daniel S. Goldman D / House
PFE logo
PFE PFIZER, INC.
Sale $15,001 - $50,000
Aug 13, 2023 Jul 12, 2023 -59.05%
Congress pfp
Daniel S. Goldman D / House
NVS logo
NVS NOVARTIS AG
Sale $50,001 - $100,000
Aug 13, 2023 Jul 10, 2023 -8.89%
Congress pfp
Lois Frankel D / House
PFE logo
PFE PFIZER, INC.
Purchase $1,001 - $15,000
Jul 28, 2023 Jun 28, 2023 -61.77%
Congress pfp
Tommy Tuberville R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Purchase $1,001 - $15,000
Jul 14, 2023 Jun 12, 2023 -68.69%
Congress pfp
Zoe Lofgren D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jun 06, 2023 May 26, 2023 -69.36%
Congress pfp
Shelley Moore Capito R / Senate
BMY logo
BMY Bristol-Myers Squibb Company Common Stock
Sale (Full) $1,001 - $15,000
Jun 14, 2023 May 10, 2023 -63.41%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC.
Purchase $1,001 - $15,000
May 19, 2023 Apr 28, 2023 -72.68%
Congress pfp
Thomas R. Carper D / Senate
NVS logo
NVS Novartis AG Common Stock
Purchase $1,001 - $15,000
May 01, 2023 Apr 26, 2023 -26.53%